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During the Mobile Genetic Elements and Genome Evolution Keystone Symposium in March 2014, the Editors of
Mobile DNA caught up with a panel of conference speakers to select key advances in the field, and hear their
thoughts on where mobile DNA research is going.Introduction
At a time when transposable elements are gaining in-
creased interest as powerful engines of genome evolu-
tion, the Keystone Symposium ‘Mobile Genetic Elements
and Genome Evolution’ in March 2014 aimed to explore
the cutting edge of mobile DNA research. In particular,
the conference focused on recent innovations in the
study of transposon biology and genome evolution, and
the evolutionary arms race that exists between mobile
DNA and their hosts. In addition, findings around active
transposition during neurogenesis and in tumor cells,
and its potential role in brain development and cancer,
was a key topic of discussion.
With so many ongoing questions and controversy
within the transposable elements community, the Edi-
tors of Mobile DNA spoke with a panel of speakers at
the meeting to hear their thoughts on key advances in
the field, the big questions at the moment and where re-
search is going.
The panel represent divergent specialties involving
mobile genetic elements, a field which is increasingly in-
teracting with other fields as the significance of trans-
posable elements is further understood.What’s the most exciting advance recently?
Marlene Belfort
I am really excited because the very fundamental work
that is done in mobile elements is becoming so hugely
applied. For instance, Haig Kazazian’s work [1] on the
role of LINE elements in various diseases, the fact that* Correspondence: mbelfort@albany.edu
1Department of Biological Sciences, Biology Building, Room 126, University at
Albany, State University of New York, 1400 Washington Avenue, Albany, NY
12222, USA
Full list of author information is available at the end of the article
© 2014 Belfort et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.LINE elements have different patterns in cancer, and not
knowing whether that’s causal or consequential. Then, at
the other end of the spectrum, the use of transposons as
landmarks in the genome to do high-throughput se-
quencing and further advance the field. Of course, part
of the advance is because of our ability to sequence these
genomes so we can really follow elements and know
where they’re going. Now it’s come full circle that the
very elements that we can follow are becoming useful in
generating the next generation of data.
Luciano Marraffini
I think one really interesting development that relates to
mobile genetic elements is the finding of CRISPRs in
phages. There’s a paper by Andrew Camilli and cowor-
kers in Nature [2], where they found that phages carry
CRISPRs. The authors isolated and sequenced Pseudo-
monas aeruginosa phages and found that some con-
tained CRISPR-Cas systems. Through an elegant set of
experiments they found that the CRISPRs on the phage
were used to attack an antiviral chromosomal island of a
bacterial host. So the phages hijacked CRISPRs for their
own benefit. I think that’s a very interesting twist in
terms of mobile genetic elements, that now phages can
use CRISPRs too.
Todd Macfarlan
My lab studies retroviral elements that are reactivated in
mouse tissues, and now there’s been a number of reports
showing that human endogenous retrovirus elements are
also expressed. HERVs appear to serve as promoters for
important long non-coding RNAs, and are probably in-
volved in rewiring gene regulatory networks in human
development. So it’s satisfying to hear that distinct retrovi-
ruses have been co-opted for regulating early embryonicLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Belfort et al. Mobile DNA 2014, 5:16 Page 2 of 4
http://www.mobilednajournal.com/content/5/1/16gene expression in mammals (an elegant case of conver-
gent evolution). We shouldn’t just be thinking of viruses
as sequences that are potentially harmful or damaging;
mammals have decided to use viruses to our selective
advantage.
What are the big questions at the moment?
Harmit Malik
For me personally, the big questions haven’t changed.
What are the evolutionary strategies that the elements
take to thwart the host defences that are in place? What
kind of arms race is played out between mobile elements
and these host defences? And can we use this new found
information, of the scale of information, to actually dis-
cover more important host defences that are going to be
important for not just the evolutionary questions that
I’m interested in, but also biomedical questions where
mobile elements may have very important roles in many
diseases.
Jef Boeke
Some of the questions about cause or consequence in
somatic transposition: what’s really the extent of it, and
what’s the biological significance of it at the end of the
day? I confess I’m still a sceptic on some aspects of the
findings and the way that people interpret them.
As one example, I think the work from Gage and
Moran and Faulkner [3-6] and others has clearly demon-
strated that there’s hopping going on in neurons and
we’re beginning to get some sense of what the numbers
are. But I’m fundamentally a selfish DNA guy, and the
idea that these elements would be jumping around to
provide a function is still very difficult to swallow. I
think an alternative explanation for those findings, that
needs to be considered, is that in the brain and in the
germ line many, many genes are expressed. It’s a very
permissive environment for expression. So perhaps this
is a common feature of the transcriptional environment
between these two tissues – they’re both permissive for
transposition. Perhaps some of the same transcription
factors are used? This might explain why we see increased
transposition in these very selected environments.
Luciano Marraffini
In CRISPR, there’s no doubt that the biggest question
is their spacer acquisition; i.e. the process by which a
short sequence of the phage DNA is integrated into the
CRISPR locus. I think this is one of the most interesting
parts of CRISPR immunity: the ability of an organism to
adapt directly using information from their environment.
It’s not precisely Darwinian, it’s more like Lamarckian
evolution. But we really don’t know anything about how
it works, and until then we may need to wait to call it a
Lamarckian process.A second question is the tremendous diversity of
CRISPR-Cas9 systems. For many of them, we don’t know
what they do. Perhaps they are serving other functions dif-
ferent than anti-phage defence, and that would be very in-
teresting. But if not, it would also be very interesting to
understand why is there so much diversity among CRISPR
systems.Lynne Maquat
There is the quote “Nothing in biology makes sense ex-
cept in the light of evolution” [7]. If we look at where we
are now, evolutionarily, and try to de novo figure out how
we got here, we will never be able to recapitulate the or-
dered development of, as one example of particular in-
terest to me, our impossibly complex post-transcriptional
regulatory network. This is because processes were con-
stantly being built upon existing processes. Considering
that the bulk of our genome is transcribed, and a lot of
the resulting RNAs are regulatory, our task at hand now is
to figure out the functional interplay of these RNAs with
each other and with other molecules in the cell. I’m sure
that some of these transcripts have no function, but a sur-
prisingly large number probably do. They don’t encode
protein, so what are they doing in the nucleus, in the cyto-
plasm or in both?Todd Macfarlan
I think there is a lack of strong evidence for a functional
requirement of most transposable element sequences.
There is growing circumstantial evidence (in some cases
quite weak) that if you knock-down a given transposable
element using siRNA approaches, there are subtle phe-
notypes. With the advent of new genome editing tools, I
expect there will be much stronger genetic evidence of a
requirement for transposable element-mediated regula-
tion of gene expression. Nonetheless there has been a
report showing that even removal of a single retroviral
LTR (within the DICER gene) can lead to a lethal pheno-
type (in the mouse) by preventing the expression of an
alternative splice variant of DICER. To me, this is the
best proof yet for a requirement for retrovirus regulatory
activity.Keith Slotkin
In my field, which is more the epigenetics field, a lot of
us ask the same biological question: While we under-
stand how a transposable element can be maintained in
a silent state and repressed over time, we don’t under-
stand its original recognition and its initial triggering to
be silenced. That’s a process and molecular mechanism
that’s been very tough to get at and a lot of labs are now
going after this question quite aggressively.
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Jef Boeke
One of the areas that I’m personally very excited about,
and a road that I’ve decided to go down, is to build ge-
nomes from scratch where every last nucleotide of mo-
bile DNA has been ruthlessly exterminated by synthesis.
That’s one of the goals of our synthetic yeast genome
project. We’re doing the experiment that we’ve talked
about at the bar at every transposon meeting, which is
taking out all the transposon DNA from an organism
and asking what will happen. Now, I’m betting that we
will get away with it in yeast and we won’t see any
phenotype that we can attribute to that. I would not be
so sanguine about saying that about humans or mammals;
I think we would definitely see phenotype differences.Marlene Belfort
I think that the field will continue to not only provide
insight into genome dynamics in healthy populations of
all different kinds, but in disease populations. An under-
studied area is the responsiveness of mobile elements to
stresses of various kinds. So I think part of the distribu-
tion of these elements results from radiations of the ele-
ments during times of stress.
I see the use of transposable elements in various forms
of genotyping in medical applications. I anticipate both
exploitation of the elements for different practical pur-
poses and, again, more fundamental insight – they’re all
in our future. But thinking about key directions the field
is going in, the thing that really popped into my mind is:
we know that they’re responsive to stress but we have
just scratched the surface. That’s where evolution lies –
our responsiveness to stress and our adaptations to the
stress – and I think that the various kinds of mobile ele-
ments including introns play a huge role here.Keith Slotkin
I think a few years ago it was clear that the field had not
taken to the rapid explosion of sequencing technologies
and other new genome-wide assays. There are a lot of
new tools available, but this community had been a little
bit slow to catch up with the new technology. Now it’s
evident that these new tools have caught on and people
have adapted and adjusted their research plans. The
number of people doing deep sequencing and looking at
transposable elements using large genome-wide datasets
that they’ve produced has increased at an exceptional
rate.
People in our field are now using state of the art tech-
nology, such as single-cell neuron sequencing. That’s a
good use of new technology, and over the next five or
ten years there’s going to be even a larger push for even
newer technology in this field such as long-read deepsequencing, which will directly benefit research on re-
petitive elements such as transposable elements.
Lynne Maquat
I got into this field through studying the molecular basis
of human diseases. I think that with a better understand-
ing of how gene expression occurs and how it’s regu-
lated, we’re going to have a much better idea of how to
develop effective therapies. It’s clear that RNA can be
used as a therapeutic target and RNA can also be used
as a therapeutic tool. With the new information we are
getting, including information on how RNA-binding pro-
teins influence RNA metabolism, I think we are entering a
new phase of developing therapeutics. That’s very exciting
and something that we and many others are pursuing.
Harmit Malik
I think the field is at a little bit of an inflection point; I
feel that technology is both a blessing and a curse in
some ways. The blessing is that we can ask questions
that we never really had the ability to ask. On the other
hand, the risk of these new methods is that you get lazy
in terms of the types of questions you ask, and you see a
lot of the “me too” adjective, where a lot of people are
doing very similar things to profile mobile elements and
different things. Now, that’s technologically challenging
at the present moment; but my concern is that once
we’ve answered questions, we don’t want to lose sight of
the very basic intellectual questions that still remain to
be addressed.
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